Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration

Beneficial Microbes

Volumn 5, Issue 1, 2014, Pages 79-88

  Hayes, C L ^a   Natividad, J M M ^a   Jury, J ^a   Martin, R ^b   Langella, P ^b   Verdu, E F ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UMR1319 MICALIS   (France)

Author keywords

Experimental colitis; Inflammation; Probiotic

Indexed keywords

BIFIDOBACTERIUM BREVE EXTRACT; CYTOKINE; DEXTRAN SULFATE; DRINKING WATER; INTERLEUKIN 10; INTERLEUKIN 12; MYELOPEROXIDASE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; COLITIS; COLON HEMORRHAGE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DEXTRAN SULFATE SODIUM INDUCED COLITIS; DIARRHEA; DISEASE SEVERITY; ENZYME ACTIVITY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN;

EXPERIMENTAL COLITIS; INFLAMMATION; PROBIOTIC;

ANIMALS; BIFIDOBACTERIUM; COLITIS; DEXTRAN SULFATE; DIARRHEA; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-12; INTESTINES; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; PROBIOTICS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84896690309     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0039     Document Type: Article

References (37)

1. Andoh, A., Imaeda, H., Aomatsu, T., Inatomi, O., Bamba, S., Sasaki, M., Saito, Y., Tsujikawa, T. and Fujiyama, Y., 2011. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. Journal of Gastroenterology 46: 479-486.
2. Bercik, P., De Giorgio, R., Blennerhassett, P., Verdu, E.F., Barbara, G. and Collins, S.M., 2002. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 123: 1205-1215.
3. Bradley, P.P., Christensen, R.D. and Rothstein, G., 1982. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60: 618-622.
4. Cooper, H.S., Murthy, S.N., Shah, R.S. and Sedergran, D.J., 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 69: 238-249.
5. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W. and Boirivant, M., 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. Journal of Immunology 174: 3237-3246.
6. Dieleman, L.A., Palmen, M.J., Akol, H., Bloemena, E., Pena, A.S., Meuwissen, S.G. and Van Rees, E.P., 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clinical and Experimental Immunology 114: 385-391.
7. Gaudier, E., Michel, C., Segain, J.P., Cherbut, C. and Hoebler, C., 2005. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. Journal of Nutrition 135: 2753-2761.
8. Grimoud, J., Durand, H., De Souza, S., Monsan, P., Ouarne, F., Theodorou, V. and Roques, C., 2010. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. International Journal of Food Microbiology 144: 42-50.
9. Hedin, C., Whelan, K. and Lindasy, J.O., 2007. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proceedings of the Nutrition Society 66: 307-315.
10. Heuvelin, E., Lebreton, C., Grangette, C., Pot, B., Cerf-Bensussan, N. and Heyman, M., 2009. Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One 4: e5184.
11. Jeon, S.G., Kayama, H., Ueda, Y., Takahashi, T., Asahara, T., Tsuji, H., Tsuji, N.M., Kiyono, H., Ma, J.S., Kusu, T., Okumura, R., Hara, H., Yoshida, H., Yamamoto, M., Nomoto, K. and Takeda, K., 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathogens 8: e1002714.
12. Kim, J.Y., Park, M.S. and Ji, G.E., 2012. Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells. World Journal of Gastroenterology 18: 1308-1318.
13. Kleessen, B., Kroesen, A.J., Buhr, H.J. and Blaut, M., 2002. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scandinavian Journal of Gastroenterology 37: 1034-1041.
14. Lammers, K.M., Brigidi, P., Vitali, B., Gionchetti, P., Rizzello, F., Caramelli, E., Matteuzzi, D. and Campieri, M., 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunolology and Medical Microbiology 38: 165-172.
15. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. and De Simone, C., 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.
16. Mallon, P., McKay, D., Kirk, S. and Gardiner, K., 2007. Probiotics for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews CD005573.
17. Mencarelli, A., Distrutti, E., Renga, B., D'Amore, C., Cipriani, S., Palladino, G., Donini, A., Ricci, P. and Fiorucci, S., 2011. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One 6: e22978.
18. Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., Reyes, J.A., Shah, S.A., LeLeiko, N., Snapper, S.B., Bousvaros, A., Korzenik, J., Sands, B.E., Xavier, R.J. and Huttenhower, C., 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology 13: R79.
19. Natividad, J.M.M., Petit, V., Huang, X., De Palma, G., Jury, J., Sanz, Y., Philpott, D., Garcia Rodenas, C.L., McCoy, K.D. and Verdu, E.F., 2012. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflammatory Bowel Diseases 18: 1434-1436.
20. Ohtsuka, Y., Ikegami, T., Izumi, H., Namura, M., Ikeda, T., Ikuse, T., Baba, Y., Kudo, T., Suzuki, R. and Shimizu, T., 2012. Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine. Pediatric Research 71: 46-53.
21. Perse, M. and Cerar, A., 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. Journal of Biomedicine and Biotechnology 2012: 718617.
22. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K. and Raz, E., 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
23. Rajilic-Stojanovic, M., Shanahan, F., Guarner, F. and De Vos, W.M., 2013. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflammatory Bowel Diseases 19: 481-488.
24. Ritchie, M.L. and Romanuk, T.N., 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7: e34938.
25. Rolfe, V.E., Fortun, P.J., Hawkey, C.J. and Bath-Hextall, F., 2006. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews CD004826.
26. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A., 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
27. Sha, S., Xu, B., Wang, X., Zhang, Y., Wang, H., Kong, X., Zhu, H. and Wu, K., 2013. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagnostic Microbiology and Infectious Disease 75: 245-251.
28. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H.M., Dore, J., Marteau, P., Seksik, P. and Langella, P., 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. Proceedings of the National Academy of Sciences of the USA 105: 16731-16736.
29. Sood, A., Midha, V., Makharia, G.K., Ahuja, V., Singal, D., Goswami, P. and Tandon, R.K., 2009. The probiotic preparation VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology 7: 1202-1209.
30. Ueno, N., Fujiya, M., Segawa, S., Nata, T., Moriichi, K., Tanabe, H., Mizukami, Y., Kobayashi, N., Ito, K. and Kohgo, Y., 2011. Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflammatory Bowel Diseases 17: 2235-2250.
31. Veerappan, G.R., Betteridge, J. and Young, P.E., 2012. Probiotics for the treatment of inflammatory bowel disease. Current Gastroenterology Reports 14: 324-333.
32. Verdu, E.F., Huang, X., Natividad, J.M.M., Lu, J., Blennerhassett, P.A., David, C.S., McKay, D.M. and Murray, J.A., 2008. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. American Journal of Physiology - Gastrointestinal and Liver Physiology 294: G217-G225.
33. Walker, A.W., Sanderson, J.D., Churcher, C., Parkes, G.C., Hudspith, B.N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G. and Petrovska, L., 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and noninflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology 11: 7.
34. Wen, K., Li, G., Bui, T., Liu, F., Li, Y., Kocher, J., Lin, L., Yang, X. and Yuan, L., 2012. High dose and low dose Lactobacilli acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30: 1198-1207.
35. Whorwell, P.J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahoney, L., Kiely, B., Shanahan, F. and Quigley, E.M.M., 2006. Efficacy of encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology 101: 1581-1590.
36. Yan, Y., Kolachala, V., Dalmasso, G., Nguyen, H., Laroui, H., Sitaraman, S.V. and Merlin, D., 2009. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4: e6073.
37. Zakostelska, Z., Kverka, M., Klimesova, K., Rossmann, P., Mrazek, J., Kopecny, J., Hornova, M., Srutkova, D., Hudcovic, T., Ridl, J. and Tlaskalova-Hogenova, H., 2011. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PloS One 6: e27961.